Paper6136932
Neuropharmacological studies in rodents on the action of RX 781094, a new selective alpha 2-adrenoceptor antagonist.
Dettmar PW and 2 others. Neuropharmacology, 1983. Cited by 64 papers, by iCite.
Cite this record
ConductScience Library. Neuropharmacological studies in rodents on the action of RX 781094, a new selective alpha 2-adrenoceptor antagonist. Papers, record 6136932. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6136932
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neuropharmacological studies in rodents on the action of RX 781094, a new selective alpha 2-adrenoceptor antagonist.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic alpha-Antagonists | Major topic |
| Cerebral Cortex | Major topic |
| Dioxins | Major topic |
| Receptors, Adrenergic | Major topic |
| Receptors, Adrenergic, alpha | Major topic |
| Animals | |
| Antihypertensive Agents | |
| Clonidine | |
| Drug Antagonism | |
| Electroencephalography | |
| Guanabenz | |
| Idazoxan | |
| Male | |
| Parietal Lobe | |
| Rats | |
| Rats, Inbred Strains | |
| Sleep | |
| Wakefulness |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7862865 | Effects of alpha-2 adrenoceptor antagonists on rough-and-tumble play in juvenile rats: evidence for a site of action independent of non-adrenoceptor imidazoline binding sites. | Psychopharmacology (Berl) | 1994 | https://conductscience.org/library/papers/7862865 | PubMed |
| 6150740 | Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems. | Br J Pharmacol | 1984 | https://conductscience.org/library/papers/6150740 | PubMed |
| 6150739 | 2-Alkyl analogue of idazoxan (RX 781094) with enhanced antagonist potency and selectivity at central alpha 2-adrenoceptors in the rat. | Br J Pharmacol | 1984 | https://conductscience.org/library/papers/6150739 | PubMed |
| 6150737 | Evidence for a peripheral component in the sympatholytic effect of clonidine in rats. | Br J Pharmacol | 1984 | https://conductscience.org/library/papers/6150737 | PubMed |
| 6147764 | Nucleus locus coeruleus: evidence for alpha 1-adrenoceptor mediated hypotension in the cat. | Naunyn Schmiedebergs Arch Pharmacol | 1984 | https://conductscience.org/library/papers/6147764 | PubMed |
| 6144048 | Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine. | Naunyn Schmiedebergs Arch Pharmacol | 1984 | https://conductscience.org/library/papers/6144048 | PubMed |
| 3894582 | Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence. | J Neural Transm | 1985 | https://conductscience.org/library/papers/3894582 | PubMed |
| 3018142 | Activation of alpha 2-adrenoreceptors enhances haloperidol-induced suppression of operant behavior. | J Neural Transm | 1986 | https://conductscience.org/library/papers/3018142 | PubMed |
| 2906748 | Behavioural effects of the alpha 2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine. | Psychopharmacology (Berl) | 1988 | https://conductscience.org/library/papers/2906748 | PubMed |
| 2906443 | The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the rat. | Psychopharmacology (Berl) | 1988 | https://conductscience.org/library/papers/2906443 | PubMed |
| 2905383 | Effect of clonidine on ultrasonic vocalization in preweaning rats. | J Neural Transm | 1988 | https://conductscience.org/library/papers/2905383 | PubMed |
| 2901129 | The alpha 2-adrenoceptor antagonists idazoxan and yohimbine increase rates of DRL responding in rats. | Psychopharmacology (Berl) | 1988 | https://conductscience.org/library/papers/2901129 | PubMed |
| 2875395 | L-654,284 a new potent and selective alpha 2-adrenoceptor antagonist. | Naunyn Schmiedebergs Arch Pharmacol | 1986 | https://conductscience.org/library/papers/2875395 | PubMed |
| 2571173 | Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan. | Psychopharmacology (Berl) | 1989 | https://conductscience.org/library/papers/2571173 | PubMed |
| 2570434 | Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. | Psychopharmacology (Berl) | 1989 | https://conductscience.org/library/papers/2570434 | PubMed |
| 2567344 | Alpha 2-adrenoceptor antagonists potentiate the anticonflict and the rotarod impairing effects of benzodiazepines. | J Neural Transm | 1989 | https://conductscience.org/library/papers/2567344 | PubMed |
| 2296619 | Idazoxan increases rough-and-tumble play, activity and exploration in juvenile rats. | Psychopharmacology (Berl) | 1990 | https://conductscience.org/library/papers/2296619 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6136932
GET https://conductscience.org/api/papers/v1/6136932/authors